These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 36011335)

  • 1. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel.
    Rutkowska L; Sałacińska K; Salachna D; Matusik P; Pinkier I; Kępczyński Ł; Piotrowicz M; Starostecka E; Lewiński A; Gach A
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
    Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z
    J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.
    Madar L; Juhász L; Szűcs Z; Kerkovits L; Harangi M; Balogh I
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
    Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
    J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
    Iacocca MA; Wang J; Sarkar S; Dron JS; Lagace T; McIntyre AD; Lau P; Robinson JF; Yang P; Knoll JH; Cao H; McPherson R; Hegele RA
    Can J Cardiol; 2018 Oct; 34(10):1316-1324. PubMed ID: 30269829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing of a gene panel in patients with familial hypercholesterolemia from Southern Poland.
    Totoń-Żurańska J; Wołkow P; Kapusta M; Wójcik M; Starzyk J; Kawalec E; Idzior-Waluś B; Waluś-Miarka M
    Pol Arch Intern Med; 2023 Jun; 133(6):. PubMed ID: 36648309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
    Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
    Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
    J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.
    Huang CC; Niu DM; Charng MJ
    J Atheroscler Thromb; 2022 May; 29(5):639-653. PubMed ID: 33994402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel large duplication (exon2_6dup): copy number variation in the LDLR gene in a large family with familial hypercholesterolemia by whole-genome sequencing.
    Hori M; Takahashi A; Hosoda K; Harada-Shiba M
    J Clin Lipidol; 2022; 16(2):167-172. PubMed ID: 35131226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
    Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
    Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia.
    Sánchez-Hernández RM; Tugores A; Nóvoa FJ; Brito-Casillas Y; Expósito-Montesdeoca AB; Garay P; Bea AM; Riaño M; Pocovi M; Civeira F; Wägner AM; Boronat M
    J Clin Lipidol; 2019; 13(4):618-626. PubMed ID: 31153816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.